SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-22-085150
Filing Date
2022-03-25
Accepted
2022-03-25 16:10:07
Documents
15
Period of Report
2022-03-25
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d262323d8k.htm   iXBRL 8-K 35099
2 EX-99.1 d262323dex991.htm EX-99.1 43492
6 GRAPHIC g262323g19v43.jpg GRAPHIC 2478
7 GRAPHIC g262323g59r55.jpg GRAPHIC 1907
  Complete submission text file 0001193125-22-085150.txt   220198

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA vir-20220325.xsd EX-101.SCH 2843
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE vir-20220325_lab.xml EX-101.LAB 17996
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE vir-20220325_pre.xml EX-101.PRE 11254
9 EXTRACTED XBRL INSTANCE DOCUMENT d262323d8k_htm.xml XML 3346
Mailing Address 499 ILLINOIS STREET SUITE 500 SAN FRANCISCO CA 94158
Business Address 499 ILLINOIS STREET SUITE 500 SAN FRANCISCO CA 94158 415-906-4324
Vir Biotechnology, Inc. (Filer) CIK: 0001706431 (see all company filings)

IRS No.: 812730369 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39083 | Film No.: 22771451
SIC: 2836 Biological Products, (No Diagnostic Substances)